BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24338606)

  • 1. Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort.
    Castellsagué X; Pawlita M; Roura E; Margall N; Waterboer T; Bosch FX; de Sanjosé S; Gonzalez CA; Dillner J; Gram IT; Tjønneland A; Munk C; Pala V; Palli D; Khaw KT; Barnabas RV; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Fagherazzi G; Kaaks R; Lukanova A; Steffen A; Trichopoulou A; Trichopoulos D; Klinaki E; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Lund E; Weiderpass E; Quirós JR; Sánchez MJ; Navarro C; Barricarte A; Larrañaga N; Ekström J; Hortlund M; Lindquist D; Wareham N; Travis RC; Rinaldi S; Tommasino M; Franceschi S; Riboli E
    Int J Cancer; 2014 Jul; 135(2):440-52. PubMed ID: 24338606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.
    Roura E; Travier N; Waterboer T; de Sanjosé S; Bosch FX; Pawlita M; Pala V; Weiderpass E; Margall N; Dillner J; Gram IT; Tjønneland A; Munk C; Palli D; Khaw KT; Overvad K; Clavel-Chapelon F; Mesrine S; Fournier A; Fortner RT; Ose J; Steffen A; Trichopoulou A; Lagiou P; Orfanos P; Masala G; Tumino R; Sacerdote C; Polidoro S; Mattiello A; Lund E; Peeters PH; Bueno-de-Mesquita HB; Quirós JR; Sánchez MJ; Navarro C; Barricarte A; Larrañaga N; Ekström J; Lindquist D; Idahl A; Travis RC; Merritt MA; Gunter MJ; Rinaldi S; Tommasino M; Franceschi S; Riboli E; Castellsagué X
    PLoS One; 2016; 11(1):e0147029. PubMed ID: 26808155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort.
    Roura E; Castellsagué X; Pawlita M; Travier N; Waterboer T; Margall N; Bosch FX; de Sanjosé S; Dillner J; Gram IT; Tjønneland A; Munk C; Pala V; Palli D; Khaw KT; Barnabas RV; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Fagherazzi G; Kaaks R; Lukanova A; Steffen A; Trichopoulou A; Trichopoulos D; Klinaki E; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Peeters PH; Lund E; Weiderpass E; Redondo ML; Sánchez MJ; Tormo MJ; Barricarte A; Larrañaga N; Ekström J; Hortlund M; Lindquist D; Wareham N; Travis RC; Rinaldi S; Tommasino M; Franceschi S; Riboli E
    Int J Cancer; 2014 Jul; 135(2):453-66. PubMed ID: 24338632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.
    Arnheim Dahlström L; Andersson K; Luostarinen T; Thoresen S; Ögmundsdottír H; Tryggvadottír L; Wiklund F; Skare GB; Eklund C; Sjölin K; Jellum E; Koskela P; Wadell G; Lehtinen M; Dillner J
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2541-50. PubMed ID: 21994401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
    Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
    Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort.
    Idahl A; Le Cornet C; González Maldonado S; Waterboer T; Bender N; Tjønneland A; Hansen L; Boutron-Ruault MC; Fournier A; Kvaskoff M; Boeing H; Trichopoulou A; Valanou E; Peppa E; Palli D; Agnoli C; Mattiello A; Tumino R; Sacerdote C; Onland-Moret NC; Gram IT; Weiderpass E; Quirós JR; Duell EJ; Sánchez MJ; Chirlaque MD; Barricarte A; Gil L; Brändstedt J; Riesbeck K; Lundin E; Khaw KT; Perez-Cornago A; Gunter MJ; Dossus L; Kaaks R; Fortner RT
    Int J Cancer; 2020 Oct; 147(8):2042-2052. PubMed ID: 32243586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.
    Dillner J; Lehtinen M; Björge T; Luostarinen T; Youngman L; Jellum E; Koskela P; Gislefoss RE; Hallmans G; Paavonen J; Sapp M; Schiller JT; Hakulinen T; Thoresen S; Hakama M
    J Natl Cancer Inst; 1997 Sep; 89(17):1293-9. PubMed ID: 9293920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
    Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
    Koskela P; Anttila T; Bjørge T; Brunsvig A; Dillner J; Hakama M; Hakulinen T; Jellum E; Lehtinen M; Lenner P; Luostarinen T; Pukkala E; Saikku P; Thoresen S; Youngman L; Paavonen J
    Int J Cancer; 2000 Jan; 85(1):35-9. PubMed ID: 10585579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
    Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
    Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.
    Safaeian M; Quint K; Schiffman M; Rodriguez AC; Wacholder S; Herrero R; Hildesheim A; Viscidi RP; Quint W; Burk RD
    J Natl Cancer Inst; 2010 Dec; 102(23):1794-804. PubMed ID: 21098758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study.
    Naucler P; Chen HC; Persson K; You SL; Hsieh CY; Sun CA; Dillner J; Chen CJ
    J Gen Virol; 2007 Mar; 88(Pt 3):814-822. PubMed ID: 17325353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples.
    Kwaśniewska A; Korobowicz E; Zdunek M; Skoczyński M; Kwaśniewski W; Daniłoś J; Goździcka-Józefiak A
    Eur J Gynaecol Oncol; 2009; 30(1):65-70. PubMed ID: 19317260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of
    Martinelli M; Musumeci R; Rizzo A; Muresu N; Piana A; Sotgiu G; Landoni F; Cocuzza C
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31514378
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras.
    Ferrera A; Baay MF; Herbrink P; Figueroa M; Velema JP; Melchers WJ
    Int J Cancer; 1997 Dec; 73(6):781-5. PubMed ID: 9399651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil.
    da Silva Barros NK; Costa MC; Alves RR; Villa LL; Derchain SF; Zeferino LC; Dos Santos Carneiro MA; Rabelo-Santos SH
    J Med Virol; 2012 Jul; 84(7):1143-50. PubMed ID: 22585734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Chlamydia trachomatis serology in conservative management of cervical intraepithelial neoplasia grade 2.
    Miralpeix E; Solé-Sedeño JM; Agramunt S; Lloveras B; Gimeno R; Alameda F; Carreras R; Mancebo G
    Int J Gynaecol Obstet; 2019 Oct; 147(1):43-48. PubMed ID: 31272132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea.
    Oh JK; Franceschi S; Kim BK; Kim JY; Ju YH; Hong EK; Chang YC; Rha SH; Kim HH; Kim JH; Kim CY; Shin HR
    Eur J Cancer Prev; 2009 Feb; 18(1):56-61. PubMed ID: 19077566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland.
    Hinkula M; Pukkala E; Kyyrönen P; Laukkanen P; Koskela P; Paavonen J; Lehtinen M; Kauppila A
    Br J Cancer; 2004 Mar; 90(5):1025-9. PubMed ID: 14997202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.